DINSMORE CAPITAL MANAGEMENT CO/NJ - SALIX PHARMACEUTICALS INC ownership

SALIX PHARMACEUTICALS INC's ticker is and the CUSIP is 795435AE6. A total of 32 filers reported holding SALIX PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 1.4%.

Quarter-by-quarter ownership
DINSMORE CAPITAL MANAGEMENT CO/NJ ownership history of SALIX PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$1,097,000
-24.2%
600,0000.0%0.43%
-24.7%
Q3 2014$1,448,000
+22.6%
600,0000.0%0.57%
+25.6%
Q2 2014$1,181,000
+16.1%
600,0000.0%0.45%
+12.7%
Q1 2014$1,017,000
+13.4%
600,0000.0%0.40%
+10.7%
Q4 2013$897,000600,0000.36%
Other shareholders
SALIX PHARMACEUTICALS INC shareholders Q1 2015
NameSharesValueWeighting ↓
TENOR CAPITAL MANAGEMENT Co., L.P. 36,001,000$95,697,00016.53%
CAPSTONE INVESTMENT ADVISORS, LLC 145,320,992$386,133,0006.28%
Verition Fund Management LLC 18,500,000$49,268,0005.72%
PIPER SANDLER & CO. 3,750,000$9,968,0004.14%
BERKLEY W R CORP 25,881,000$68,886,0003.58%
WOLVERINE ASSET MANAGEMENT LLC 31,256,000$83,048,0001.66%
TT INTERNATIONAL 760,000$2,020,0001.41%
FARALLON CAPITAL MANAGEMENT LLC 31,014,000$82,372,0001.20%
CSS LLC/IL 8,300,000$22,057,0001.12%
SG Americas Securities, LLC 370,000$98,536,0000.59%
View complete list of SALIX PHARMACEUTICALS INC shareholders